MYLAN CF 135 MYLAN CF 135 Pill - blue & yellow capsule/oblong
Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Mylan Pharmaceuticals Inc.
Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN CF 135 MYLAN CF 135
Fenofibric Acid Delayed-Release
- Imprint
- MYLAN CF 135 MYLAN CF 135
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
gelatin,
hydroxypropyl cellulose,
hypromelloses,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polysorbate 80,
povidone,
sodium lauryl sulfate,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
FD&C Blue No. 2,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2590 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0196 (Discontinued) | UDL Laboratories Inc. |
More about fenofibric acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
